Lidocan Iii Patch
Product Images NDC 59088-907

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lidocan Iii (NDC 59088-907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puretek Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drug (Drug Asso)

Drug (Drug Asso)
This is a list of examples of different classes of drugs. It includes nitrates/nitrites such as nitric oxide, nitroglycerin, etc. as well as local anesthetics like articaine, benzocaine, etc. There are also antineoplastic agents, antibiotics, antimalarials, anticonvulsants, and other drugs like acetaminophen, metoclopramide, etc.*
FDA Label Image

Label (Label)

Label (Label)
The text appears to be a description of a medication called "Lidocaine Patch 5%". Each adhesive patch contains 700 mg of Lidocaine in an aqueous base. The inactive ingredients include purified water, glycerin, sorbitol, polyacrylic acid, and various other substances. The usual dosage is up to 3 patches, and the patches should be stored at room temperature. The text also includes directions for use, such as not storing the patch outside the sealed envelope, removing the release liner before applying the patch, and avoiding contact with water. The patches should be folded and safely discarded after use. The medication is distributed by PureTek Com. and marketed by YARAL Pharma, Inc. It is manufactured by Altergon Italia Srl.*
FDA Label Image

Graphs (Graphs)

FDA Label Image

Molecule (Molecule)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.